Episode
A conversation with Sam LaCrosse, a self-described nobody
A conversation with Sam LaCrosse, a self-described nobody We speak with Sam Lacrosse, author of Value Economics: The Study of ...
A conversation with Dr. Red Lawhern on the comments concerning the CDC opioid prescribing guidelines for chronic pain
We discuss trends in the comments that have appeared in response to the draft version of the updated clinical practice ...
A conversation with Dr. Thomas Kline & Jonelle Elgaway of the National Pain Council
Today we are here with Dr. Thomas Kline and Jonelle Elgaway, of the National Pain Council, a citizen's group with ...
A conversation with Mr. Adam Marcus, co-founder of Retraction Watch and editor for Primary Care at Medscape
We discuss the rise in retractions among academic publications, and the pandemic's impact on retractions in clinical journals over the ...
A conversation with Dr. John Whyte, Chief Medical Officer of WebMD and author of the new book, Take Control of Your Diabetes Risk
We discuss Dr. John Whyte's latest book, Take Control of Your Diabetes Risk, and reveal what it offers patients struggling ...
A conversation with Miss Tara Haelle, a health journalist and subject matter expert on vaccines
We discuss Miss Haelle's struggles to overcome vaccine misinformation during the pandemic. As a journalist, she often found herself at ...
A conversation with Miss Sandra Lamb, an award winning journalist and author
We discuss Miss Lamb’s experiences during the pandemic and glean her thoughts on how it affected the quality of writing ...
A conversation with Miss Andrea King Collier, author and award winning health journalist
We discuss her journalism as a writer and lived experiences as a patient during the pandemic, chronicling a timeline of ...
A conversation with Mr. John Tassoni, addiction policy expert and lobbyist at The Sentinel Group
We discuss addiction policies in Rhode Island and demonstrate how bureaucracies can influence the passing of addiction policy and law. ...
A conversation with Miss Leah Samuel, health and equity editor for The Conversation
We discuss health and equity in a post-pandemic world. While health and equity may be the future of medicine, its ...
A conversation with Mr. Ron Chapman, of Chapman Law Group, on Ruan v. United States
We discuss the oral arguments presented on March 1st in the seminal case, Ruan v. United States - arguably the ...
A conversation with Dr. Jeff Singer, Senior Fellow at the Cato Institute
We discuss the proposed changes to the CDC opioid prescribing guidelines and challenge false notions on opioids, prohibition, and addiction. ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more